ARTICLE

Volume 10,Issue 4

Cite this article
1
Download
5
Citations
14
Views
20 December 2025

Clinical Study on the Treatment of Cervical HPV Infection with Yiqi Chushijiedu Decoction

Xia Wu1
Show Less
1 Rugao Center for Disease Control and Prevention, Rugao 226500, Jiangsu, China
APM 2025 , 10(4), 213–219; https://doi.org/10.18063/APM.v10i4.1050
© 2025 by the Author. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Objective: To analyze the actual effect of Yiqi Chushijiedu Decoction in the treatment of cervical human papillomavirus (HPV) infection. Methods: 80 patients with cervical HPV infection were randomly divided into a control group and an observation group, 40 cases each. The control group received conventional therapy, while the observation group received Yiqichushijiedu decoction in addition to conventional therapy. Compare the traditional Chinese medicine syndrome scores, HPV negative conversion, changes in immune function indicators and the probability of adverse reactions between the two groups before and after treatment. Results: After treatment, the TCM syndrome score of the observation group was lower than that of the control group, the HPV negative conversion rate was higher than that of the control group, the improvement of immune function was better than that of the control group, and the incidence of adverse reactions was lower than that of the control group. These differences were statistically significant (p < 0.05). Conclusion: Yiqi Chushi Jiedu Decoction has obvious therapeutic effect on cervical HPV infection. It can improve the clinical symptoms of patients, turn more HPV negative, regulate immune function and has good safety, so it is suitable for clinical promotion.

Keywords
Cervical HPV infection
Yiqi Chushijiedu Decoction
TCM syndrome score
HPV negative conversion rate
Immune function
References

[1] Yang Q, Lu S, 2024, Effect of Qingre Huashi Jiedu Decoction Combined with Recombinant Human Interferon α-2b in the Treatment of Cervicitis Combined with Human Papillomavirus Infection. World Compound Medicine (Chinese and English), 10(11): 15–19.

[2] Li S, Zhang E, Wang L, et al., 2025, Yiqi Huayu Jiedu Decoction Combined with Interferon in the Treatment of Persistent Cervical High-Risk Human Papillomavirus Infection. Acta Traditional Chinese Medicine, 40(05): 1121–1126.

[3] Chen Y, Qiu B, Li L, et al., 2024, Yiqi Huashijiedu Decoction Assisting Recombinant Human Interferon α-2b Gel in the Treatment of Chronic Cervicitis and Its Effect on NKTs and IL-4. Chinese Journal of Traditional Chinese Medicine, 42(03): 74–76.

[4] Li J, 2023, Effect of Chushi Yiqi Jiedu Decoction Combined with Western Medicine in the Treatment of Cervical HPV Infection on HPV Negative Conversion. Marriage, Parenting and Health, 29(03): 61–63.

[5] Wang Y, Jiang W, Li C, et al., 2023, Clinical Study on Modified Lishijiedu Decoction Combined with Recombinant Human Interferon α-2b Gel in the Treatment of High-Risk HPV Infection. New Chinese Medicine, 55(02): 111–114.

[6] Sheng H, Chen B, Jiang L, 2022, Clinical Observation of Zheng’s Fuzheng Jiedu Decoction Combined with Interferon in the Treatment of Low-Grade Cervical Intraepithelial Neoplasia Accompanied by High-Risk HPV Infection. Journal of Contemporary Clinical Medicine, 35(06): 95–96.

[7] Zhao J, Liu L, Hu X, 2022, Research Progress of Traditional Chinese Medicine in the Treatment of High-Risk HPV Infection Based on Regulating Vaginal Microecology. Journal of Traditional Chinese Medicine, 50(09): 105–109.

Share
Back to top